查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1457354

神经介入设备的全球市场:按产品类型,最终用户,地区 - 全球产业分析、规模、占有率、成长、趋势、预测（2023-2030）

Neurointerventional Device Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 209 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2023年全球神经介入器材市场规模将达260亿美元，并以4.7%的复合年增长率扩张，2030年底将达358亿美元。

重要见解

  • 神经介入器材市场规模（2023年）：260亿美元
  • 预测市场规模（2030F）：358亿美元
  • 全球市场成长率（2023-2030年复合年增长率）：4.7%
  • 过去的市场成长率（2018-2022年复合年增长率）：4.3%

神经介入设备市场 - 报告范围：

神经介入设备市场包括广泛的医疗设备和用于诊断和治疗各种神经系统疾病的微创手术的设备。这些装置包括支架、栓塞线圈、导管、分流器等。市场的成长是由技术进步、神经系统疾病盛行率增加以及对微创外科手术的需求不断增长等因素所推动的。此外，老年人口的增加以及随之而来的与年龄相关的神经系统疾病的快速增加进一步推动了市场的扩张。

市场驱动因素：

全球神经介入器材市场主要受到中风、动脉瘤和脑血管畸形等神经系统疾病盛行率上升的推动。神经介入治疗设备的技术进步，例如生物可吸收支架和先进成像技术的开发，显着改善了患者的治疗效果并降低了该技术的风险。此外，越来越多地采用微创神经介入技术，其特点是住院时间更短，恢復时间更短，也推动了市场的成长。

市场限制因素：

儘管成长前景广阔，但神经介入器材市场面临严格的监管要求、高技术成本和限制性报销政策等挑战。此外，对某些神经介入设备的长期疗效和安全性的担忧，以及与设备相关併发症相关的风险，对市场扩张构成了重大障碍。应对这些挑战需要持续投资研发，并采取严格的品质控制措施，以确保产品的安全性和有效性。

市场机会：

由于持续的技术创新和对个人化医疗日益增长的兴趣，神经介入设备市场提供了利润丰厚的机会。MRI 和 CT 血管造影等影像技术的进步促进了准确的诊断和治疗计划，从而扩大了神经介入技术的范围。此外，医疗保健基础设施投资的增加，特别是在新兴国家，正在为神经介入设备的采用创造有利的市场条件。产业参与者和医疗保健提供者共同努力开发针对特定神经系统疾病的创新治疗解决方案，将进一步扩大市场成长机会。

本报告解决的关键问题

  • 推动神经介入设备市场成长的关键因素是什么？
  • 哪些神经系统疾病为市场扩张提供了最大的机会？
  • 科技进步如何改变神经介入设备市场的竞争格局？
  • 谁是神经介入设备市场的主要参与者？他们采取什么策略来维持其市场地位？
  • 全球神经介入器材市场有哪些新趋势和未来前景？

竞争资讯与经营策略：

全球神经介入设备市场的主要参与者：Abbott Laboratories、Becton, Dickinson and Company（BD）、Bio-Rad Laboratories, Inc.、Danaher Corporation（Cepheid）、F. Hoffmann-La Roche Ltd.（Roche Diagnostics）、Abbott Laboratories、Becton, Dickinson and Company（BD）、Bio-Rad Laboratories, Inc.（Roche Diagnostics）、Hologic, Inc.、Laboratory Corporation of America Holdings、PerkinElmer, Inc.、Quest Diagnostics、Thermo Fisher Scientific, Inc.等。专注于技术创新和策略联盟，以提高其在市场上的影响力。这些公司正在大力投资研发，推出新的神经介入设备，以满足未满足的临床需求并改善患者的治疗效果。与医疗机构和学术研究中心的合作加速了尖端技术的发展并加速了临床证据的产生。此外，对医生培训计划和患者教育计划的重视推动了市场渗透并维持竞争激烈的神经介入设备市场的长期成长。

主要公司简介

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.

神经介入设备市场的研究细分：

按产品

  • 栓塞线圈
  • 颈动脉支架
  • 颅内支架
  • 神经血管血栓切除术
  • 栓塞保护装置
  • 分流装置
  • 囊内装置
  • 液体栓塞
  • 气球
  • 支架回收器

按技术

  • 神经血栓切除术
  • 脑血管摄影
  • 支架置入
  • 捲取技术
  • 血流障碍

由最终用户

  • 医院
  • 门诊手术中心

按地区

  • 北美
  • 欧洲
  • 东亚
  • 南亚/大洋洲
  • 拉丁美洲
  • 中东/非洲

目录

第一章内容提要

第二章市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 产品生命週期分析
  • 神经介入设备市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 应用清单
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长率展望
    • 全球母公司市场概览
  • 预测变量 - 相关性和影响
  • 监管和技术格局

第三章全球神经介入设备市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
    • 市场数量（单位）预测
    • 市场规模及年成长率
    • 绝对的财务机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2013-2016
    • 目前市场规模预测，2018-2026
  • 全球神经介入设备市场展望：产品
    • 简介/主要发现
    • 2018-2022 年依产品历史市场规模（百万美元）及销售量（单位）分析
    • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
    • 市场吸引力分析：产品
  • 全球神经介入设备市场展望：技术
    • 简介/主要发现
    • 2018-2022 年按技术划分的历史市场规模（百万美元）和数量（单位）分析
    • 2023-2030 年按技术划分的当前市场规模（百万美元）和数量（单位）预测
    • 市场吸引力分析：技术
  • 全球神经介入设备市场展望：最终用户
    • 简介/主要发现
    • 2018-2022 年历史市场规模（百万美元）和最终用户数量（单位）分析
    • 2023-2030 年最终用户目前市场规模（百万美元）与销售量（单位）预测
    • 市场吸引力分析：最终用户

第四章全球神经介入设备市场展望：地区

  • 主要亮点
  • 2018-2022 年按地区历史市场规模（百万美元）及成交量（单位）分析
  • 2023-2030 年各地区目前市场规模（百万美元）及销售量（单位）预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：区域

第五章北美神经介入设备市场展望：过去（2018-2022）与预测（2023-2030）

第六章欧洲神经介入设备市场展望：过去（2018-2022）与预测（2023-2030）

第七章东亚神经介入器材市场展望：过去（2018-2022）与预测（2023-2030）

第8章南亚/大洋洲神经介入设备市场展望：过去（2018-2022）与预测（2023-2030）

第9章拉丁美洲神经介入设备市场展望：过去（2018-2022）与预测（2023-2030）

第10章中东和非洲神经介入设备市场展望：过去（2018-2022）和预测（2023-2030）

第十一章竞争格局

  • 2022 年市场占有率分析
  • 市场结构
  • 公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company（BD）
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation（Cepheid）
    • F. Hoffmann-La Roche Ltd.（Roche Diagnostics）
    • Hologic, Inc.
    • Laboratory Corporation of America Holdings
    • PerkinElmer, Inc.
    • Quest Diagnostics
    • Thermo Fisher Scientific, Inc.

第十二章附录

简介目录
Product Code: PMRREP33941

Persistence Market Research presents a comprehensive analysis of the global neurointerventional device market, offering valuable insights into the industry's dynamics, growth drivers, challenges, and emerging trends. This report delivers an exclusive overview of the market's structure, backed by data and statistics that project the market's trajectory from 2023 to 2030.

The global neurointerventional device market is forecast to expand at a CAGR of 4.7% and thereby increase from a value of US$26 Bn in 2023, to US$ 35.8 Bn by the end of 2030.

Key Insights:

  • Neurointerventional Device Market Size (2023E): US$26 Bn
  • Projected Market Value (2030F): US$35.8 Bn
  • Global Market Growth Rate (CAGR 2023 to 2030): 4.7%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.3%

Neurointerventional Device Market - Report Scope:

The neurointerventional device market encompasses a wide array of medical devices and equipment used in minimally invasive procedures to diagnose and treat various neurological conditions. These devices include stents, embolization coils, catheters, and flow diverters, among others. The market's growth is driven by factors such as technological advancements, increasing prevalence of neurological disorders, and growing demand for minimally invasive surgical procedures. Moreover, the rising geriatric population and the subsequent surge in age-related neurological ailments further propel market expansion.

Market Growth Drivers:

The global neurointerventional device market is primarily fueled by the escalating prevalence of neurological disorders such as stroke, aneurysms, and cerebral vascular malformations. Technological advancements in neurointerventional devices, including the development of bioresorbable stents and advanced imaging techniques, have significantly improved patient outcomes and reduced procedural risks. Additionally, the growing adoption of minimally invasive neurointerventional procedures, characterized by shorter hospital stays and quicker recovery times, augments market growth.

Market Restraints:

Despite promising growth prospects, the neurointerventional device market faces challenges such as stringent regulatory requirements, high procedural costs, and limited reimbursement policies. Moreover, concerns regarding the long-term efficacy and safety of certain neurointerventional devices, along with the risks associated with device-related complications, pose significant barriers to market expansion. Addressing these challenges requires sustained investments in research and development, along with stringent quality control measures to ensure product safety and efficacy.

Market Opportunities:

The neurointerventional device market presents lucrative opportunities driven by ongoing technological innovations and a growing focus on personalized medicine. Advancements in imaging technologies such as MRI and CT angiography facilitate precise diagnosis and treatment planning, thereby expanding the scope of neurointerventional procedures. Furthermore, increasing investments in healthcare infrastructure, particularly in emerging economies, create favorable market conditions for the adoption of neurointerventional devices. Collaborative efforts between industry players and healthcare providers to develop innovative treatment solutions tailored to specific neurological conditions further unlock growth opportunities in the market.

Key Questions Answered in the Report:

  • What are the key factors driving the growth of the neurointerventional device market?
  • Which neurological conditions represent the most significant opportunities for market expansion?
  • How are technological advancements reshaping the competitive landscape of the neurointerventional device market?
  • Who are the leading players in the neurointerventional device market, and what strategies are they employing to maintain their market positions?
  • What are the emerging trends and future prospects in the global neurointerventional device market?

Competitive Intelligence and Business Strategy:

Key players in the global neurointerventional device market, including Abbott Laboratories, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd. (Roche Diagnostics), Hologic, Inc., Laboratory Corporation of America Holdings, PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific, Inc., focus on innovation and strategic collaborations to enhance their market presence. These companies invest heavily in research and development to introduce novel neurointerventional devices that address unmet clinical needs and offer improved patient outcomes. Collaborations with healthcare institutions and academic research centers facilitate the development of cutting-edge technologies and foster clinical evidence generation. Moreover, emphasis on physician training programs and patient education initiatives enhances market penetration and sustains long-term growth in the competitive neurointerventional device market.

Key Companies Profiled:

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.

Neurointerventional Device Market Research Segmentation:

By Product:

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Neurovascular Thrombectomy
  • Embolic Protection Device
  • Flow Diverters Device
  • Intrasaccular Device
  • Liquid Embolic
  • Balloons
  • Stent Retrievers

By Technique:

  • Neurothrombectomy Procedure
  • Cerebral Angiography
  • Stenting
  • Coiling Procedures
  • Flow Disruption

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neurointerventional Device Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. Neurointerventional Device Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Neurointerventional Device Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Embolic Coils
      • 3.3.3.2. Carotid Stents
      • 3.3.3.3. Intracranial Stents
      • 3.3.3.4. Neurovascular Thrombectomy
      • 3.3.3.5. Embolic Protection Device
      • 3.3.3.6. Flow Diverters Device
      • 3.3.3.7. Intrasaccular Device
      • 3.3.3.8. Liquid Embolic
      • 3.3.3.9. Balloons
      • 3.3.3.10. Stent Retrievers
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Neurointerventional Device Market Outlook: Technique
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
      • 3.5.3.1. Neurothrombectomy Procedure
      • 3.5.3.2. Cerebral Angiography
      • 3.5.3.3. Stenting
      • 3.5.3.4. Coiling Procedures
      • 3.5.3.5. Flow Disruption
  • 3.6. Market Attractiveness Analysis: Technique
  • 3.7. Global Neurointerventional Device Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Ambulatory Surgical Centers
  • 3.8. Market Attractiveness Analysis: End User

4. Global Neurointerventional Device Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Technique
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Embolic Coils
    • 5.5.2. Carotid Stents
    • 5.5.3. Intracranial Stents
    • 5.5.4. Neurovascular Thrombectomy
    • 5.5.5. Embolic Protection Device
    • 5.5.6. Flow Diverters Device
    • 5.5.7. Intrasaccular Device
    • 5.5.8. Liquid Embolic
    • 5.5.9. Balloons
    • 5.5.10. Stent Retrievers s
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 5.6.1. Neurothrombectomy Procedure
    • 5.6.2. Cerebral Angiography
    • 5.6.3. Stenting
    • 5.6.4. Coiling Procedures
    • 5.6.5. Flow Disruption
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.7.1. Hospitals
    • 5.7.2. Ambulatory Surgical Centers
  • 5.8. Market Attractiveness Analysis

6. Europe Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Technique
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Embolic Coils
    • 6.5.2. Carotid Stents
    • 6.5.3. Intracranial Stents
    • 6.5.4. Neurovascular Thrombectomy
    • 6.5.5. Embolic Protection Device
    • 6.5.6. Flow Diverters Device
    • 6.5.7. Intrasaccular Device
    • 6.5.8. Liquid Embolic
    • 6.5.9. Balloons
    • 6.5.10. Stent Retrievers
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 6.6.1. Neurothrombectomy Procedure
    • 6.6.2. Cerebral Angiography
    • 6.6.3. Stenting
    • 6.6.4. Coiling Procedures
    • 6.6.5. Flow Disruption
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.7.1. Hospitals
    • 6.7.2. Ambulatory Surgical Centers
  • 6.8. Market Attractiveness Analysis

7. East Asia Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Technique
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Embolic Coils
    • 7.5.2. Carotid Stents
    • 7.5.3. Intracranial Stents
    • 7.5.4. Neurovascular Thrombectomy
    • 7.5.5. Embolic Protection Device
    • 7.5.6. Flow Diverters Device
    • 7.5.7. Intrasaccular Device
    • 7.5.8. Liquid Embolic
    • 7.5.9. Balloons
    • 7.5.10. Stent Retrievers
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 7.6.1. Neurothrombectomy Procedure
    • 7.6.2. Cerebral Angiography
    • 7.6.3. Stenting
    • 7.6.4. Coiling Procedures
    • 7.6.5. Flow Disruption
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.7.1. Hospitals
    • 7.7.2. Ambulatory Surgical Centers
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Technique
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Embolic Coils
    • 8.5.2. Carotid Stents
    • 8.5.3. Intracranial Stents
    • 8.5.4. Neurovascular Thrombectomy
    • 8.5.5. Embolic Protection Device
    • 8.5.6. Flow Diverters Device
    • 8.5.7. Intrasaccular Device
    • 8.5.8. Liquid Embolic
    • 8.5.9. Balloons
    • 8.5.10. Stent Retrievers
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 8.6.1. Neurothrombectomy Procedure
    • 8.6.2. Cerebral Angiography
    • 8.6.3. Stenting
    • 8.6.4. Coiling Procedures
    • 8.6.5. Flow Disruption
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.7.1. Hospitals
    • 8.7.2. Ambulatory Surgical Centers
  • 8.8. Market Attractiveness Analysis

9. Latin America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Technique
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Embolic Coils
    • 9.5.2. Carotid Stents
    • 9.5.3. Intracranial Stents
    • 9.5.4. Neurovascular Thrombectomy
    • 9.5.5. Embolic Protection Device
    • 9.5.6. Flow Diverters Device
    • 9.5.7. Intrasaccular Device
    • 9.5.8. Liquid Embolic
    • 9.5.9. Balloons
    • 9.5.10. Stent Retrievers
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 9.6.1. Neurothrombectomy Procedure
    • 9.6.2. Cerebral Angiography
    • 9.6.3. Stenting
    • 9.6.4. Coiling Procedures
    • 9.6.5. Flow Disruption
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.7.1. Hospitals
    • 9.7.2. Ambulatory Surgical Centers
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Technique
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Embolic Coils
    • 10.5.2. Carotid Stents
    • 10.5.3. Intracranial Stents
    • 10.5.4. Neurovascular Thrombectomy
    • 10.5.5. Embolic Protection Device
    • 10.5.6. Flow Diverters Device
    • 10.5.7. Intrasaccular Device
    • 10.5.8. Liquid Embolic
    • 10.5.9. Balloons
    • 10.5.10. Stent Retrievers
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 10.6.1. Neurothrombectomy Procedure
    • 10.6.2. Cerebral Angiography
    • 10.6.3. Stenting
    • 10.6.4. Coiling Procedures
    • 10.6.5. Flow Disruption
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.7.1. Hospitals
    • 10.7.2. Ambulatory Surgical Centers
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott Laboratories
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Becton, Dickinson and Company (BD)
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Bio-Rad Laboratories, Inc.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Danaher Corporation (Cepheid)
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Hologic, Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Laboratory Corporation of America Holdings
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. PerkinElmer, Inc.
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quest Diagnostics
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Thermo Fisher Scientific, Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations